Shares of Renalytix Plc (LON:RENX – Get Free Report) rose 9.5% during mid-day trading on Monday . The stock traded as high as GBX 15 ($0.19) and last traded at GBX 15 ($0.19). Approximately 436,377 shares changed hands during mid-day trading, a decline of 21% from the average daily volume of 551,469 shares. The stock had previously closed at GBX 13.70 ($0.18).
Renalytix Stock Up 29.2 %
The firm has a 50 day simple moving average of GBX 15.28 and a two-hundred day simple moving average of GBX 22.58. The stock has a market capitalization of £26.11 million, a P/E ratio of -45.00 and a beta of 1.98. The company has a quick ratio of 2.42, a current ratio of 0.59 and a debt-to-equity ratio of 173.95.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Read More
- Five stocks we like better than Renalytix
- Insider Trading – What You Need to Know
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- Trading Halts Explained
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- What Are Dividend Challengers?
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
